Latest News and Press Releases

FREEHOLD, N.J., Dec. 8, 2005 (PRIMEZONE) -- New Life Scientific, Inc. (OTCBB:NWLF) announced today that a speculative buy rating has been issued by Spelman Research, an investment research firm....

FREEHOLD, N.J. and SACRAMENTO, Calif., Dec. 6, 2005 (PRIMEZONE) -- New Life Scientific, Inc. (OTCBB:NWLF) and Telomolecular Corp., have announced a strategic alliance to develop products that treat...

FREEHOLD, N.J., Nov. 1, 2005 (PRIMEZONE) -- New Life Scientific, Inc. (OTCBB:NWLF) announced today that a major European pharmaceutical company has signed a contract for just under $1,000,000 with...

FREEHOLD, N.J., Oct. 14, 2005 (PRIMEZONE) -- New Life Scientific, Inc. (OTCBB:NWLF) today announced that as part of the Agreement with CureLab, Inc. both companies identified an anti-infective...

FREEHOLD, N.J., Sept. 29, 2005 (PRIMEZONE) -- New Life Scientific, Inc. (OTCBB:NWLF) announced Thursday it will expand its services to offer market research and regulatory services through Pharma...

FREEHOLD, N.J., Sept. 23, 2005 (PRIMEZONE) -- New Life Scientific, Inc. (OTCBB:NWLF) today announced the signing of a Letter of Intent with CureLab, Inc. for a long-term Joint Development and...

FREEHOLD, N.J., Sept. 1, 2005 (PRIMEZONE) -- New Life Scientific, Inc. ("New Life") (OTCBB:NWLF) www.newlifesci.com, an emerging bio-tech company, today announced that it will be a presenting company...

FREEHOLD, N.J., Aug. 1, 2005 (PRIMEZONE) -- Professor V.A. Kordyum, Doctor of Sciences, Research and Development Partner of New Life Scientific, Inc. (OTCBB:NWLF), will present his report on "Genomic...

FREEHOLD, N.J., July 19, 2005 (PRIMEZONE) -- New Life Scientific (OTCBB:NWLF) and Invapharm LLC have announced that their collaborative effort "Invamed" has reached a significant corporate milestone...

FREEHOLD, N.J., July 8, 2005 (PRIMEZONE) -- New Life Scientific, Inc. (OTCBB:NWLF) announced today that its company information will be made available via Standard & Poor's Market Access Program,...